Spanish for pediatric liver disease clinic nurses — the mother who cannot understand why her feeding-well baby needs emergency liver surgery, the mother who cannot understand why her daughter who never had hepatitis needs long-term steroids, and the father who cannot understand why his non-drinking son has fatty liver disease

Three pediatric liver disease clinic conversations: Sofía Ramos-Gutiérrez, 6 weeks, from Houston, whose mother cannot understand why a baby eating well needs urgent Kasai surgery, not knowing biliary atresia is conjugated hyperbilirubinemia that is never physiological and the surgical success window closes by 90 days; Carmen Delgado-Estrada, 12, from San Antonio, whose mother cannot understand why her daughter who never had viral hepatitis needs long-term immunosuppression, not knowing autoimmune hepatitis is a T-cell immune attack on hepatocyte antigens — no virus, not contagious, not caused by behavior; and Diego Martínez-Reyes, 14, from Dallas, whose father cannot understand why a teenager who does not drink has fatty liver disease, not knowing insulin resistance in metabolic syndrome drives hepatic de novo lipogenesis through a mechanism entirely independent of alcohol.

The pediatric liver disease clinic nurse’s communication challenge

Pediatric liver disease is a specialty in which the nurse’s communication task almost always begins with dismantling a pre-existing mental model before the clinical explanation can be heard. Parents of children with liver disease arrive holding one of three well-entrenched frameworks — newborn jaundice is normal and resolves by itself; hepatitis is a viral infection from a blood exposure or sexual contact; fatty liver disease is what happens to people who drink — and these frameworks actively resist the correct diagnosis because they predict that the situation does not require the urgency, the immunosuppression, or the monitoring the clinical team is recommending.

Three conversations from a pediatric liver disease clinic illustrate three distinct versions of this problem. In the first, a mother’s model of jaundice as physiological and self-resolving leads her to question the urgency of a surgery whose therapeutic window is closing week by week. In the second, a mother’s model of hepatitis as viral and contagious leads her to search for an exposure source that does not exist in her daughter’s diagnosis. In the third, a father’s model of fatty liver as alcoholic liver disease leads him to interpret the diagnosis as an accusation rather than a metabolic finding.

In each case the gap is etiological. Closing it requires the nurse to explain biliary anatomy and surgical timing, the mechanism of immune self-tolerance failure, and the metabolic pathway from insulin resistance to hepatic lipogenesis. These mechanisms are the actual explanations for the diagnoses — not simplifications of them — and the clinical consequences of not communicating them accurately range from a surgery performed outside its window of effectiveness to a family that stops a child’s immunosuppression because “she seems fine” to an adolescent whose modifiable liver fibrosis trajectory is never addressed because his father does not understand why the monitoring matters.


Scenario 1: Sofía Ramos-Gutiérrez — 6 weeks old, Houston, Texas

Sofía Ramos-Gutiérrez had been referred urgently to the pediatric liver disease clinic from the pediatric gastroenterology team after six weeks of persistent jaundice that had failed to resolve as expected. The referring labs were alarming: total bilirubin 11.2 mg/dL with a direct fraction of 7.8 mg/dL — sixty-nine percent direct, when any direct bilirubin greater than twenty percent of total in a newborn is pathological. Her gamma-glutamyl transferase was 312 U/L. Her mother had been noting pale, clay-colored stools for three weeks. Her urine had been dark amber — “como té fuerte,” Claudia had told the referring pediatrician. The liver biopsy performed by the gastroenterology team showed bile duct proliferation, portal fibrosis, and bile plugging — the histological picture of biliary atresia. The surgical team had been consulted and had confirmed the diagnosis. The recommended operation — Kasai portoenterostomy — was scheduled for four days from now.

Claudia Ramos-Fuentes, an office cleaner who worked nights, had brought Sofía to every appointment and had asked the same question at each one: why did Sofía need surgery when she was eating well, gaining weight, and meeting her developmental milestones? She had seen her sister’s baby turn yellow two days after birth and be completely normal by two weeks. She had a model of newborn jaundice as benign and self-resolving, and Sofía’s persistent yellow color had not produced any symptoms Claudia could perceive as dangerous.

“Yo soy madre, y conozco a mi bebé,” she said to pediatric liver disease clinic nurse Gabriela Morales-Vega. “Sofía come bien, duerme, me mira. La bebé de mi hermana estuvo amarilla dos semanas y no le pasó nada. ¿Por qué el médico dice que mi bebé necesita una cirugía del hígado en cuatro días cuando Sofía está bien?”

(I am a mother, and I know my baby. Sofía eats well, sleeps, looks at me. My sister’s baby was yellow for two weeks and nothing happened to her. Why does the doctor say my baby needs liver surgery in four days when Sofía is fine?)

Gabriela had anticipated this exact question. The clinical team had discussed it in the morning huddle: Claudia’s visible distress was not resistance to the diagnosis — it was a logical consequence of applying the correct framework to the wrong type of jaundice. The first task was to separate the two types.

“Tiene razón en confiar en lo que ve: Sofía come bien y se ve alerta. Eso es verdad,” Gabriela said. “El problema es que hay dos tipos de ictericia en los bebés, y parecen iguales desde afuera pero son completamente diferentes por dentro. El tipo que tuvo la bebé de su hermana — la ictericia normal del recién nacido — y el tipo que tiene Sofía. Quiero explicarle la diferencia, porque la diferencia es por qué la cirugía no puede esperar.”

(You are right to trust what you see: Sofía eats well and looks alert. That is true. The problem is that there are two types of jaundice in babies, and they look the same from the outside but are completely different on the inside. The type your sister’s baby had — normal newborn jaundice — and the type Sofía has. I want to explain the difference to you, because the difference is why the surgery cannot wait.)

Claudia nodded. “Adelante.” (Go ahead.)

“La ictericia normal del recién nacido ocurre porque los bebés rompen los glóbulos rojos fetales después del nacimiento — los glóbulos fetales son diferentes a los de los adultos — y el hígado inmaduro del bebé procesa ese color más lentamente que el de un adulto. El color amarillo se acumula en la piel. Pero el color en esa ictericia es lo que llamamos bilirrubina indirecta o no conjugada — una forma que el hígado todavía no ha procesado completamente. Esa forma no pasa a la orina, porque los riñones no la pueden filtrar. Por eso en la ictericia normal la orina del bebé es pálida y amarilla, y las heces son del color normal — amarillo mostaza.”

(Normal newborn jaundice occurs because babies break down fetal red blood cells after birth — fetal cells are different from adult cells — and the baby’s immature liver processes that color more slowly than an adult liver would. The yellow color accumulates in the skin. But the color in that jaundice is what we call indirect or unconjugated bilirubin — a form that the liver has not yet fully processed. That form does not pass into the urine, because the kidneys cannot filter it. That is why in normal jaundice the baby’s urine is pale and yellow and the stools are their normal color — mustard yellow.)

Claudia was listening intently. “¿Y Sofía?” (And Sofía?)

“Sofía tiene algo diferente. En Sofía, el hígado sí está procesando la bilirrubina — conjugando la bilirrubina, en términos médicos — pero esa bilis procesada no puede salir del hígado al intestino. Los conductos biliares — los tubos que normalmente llevan la bilis del hígado al intestino — están cerrados. La bilis se queda atrapada en el hígado. Cuando la bilis procesada no puede salir por los conductos, se sale por otro lado: pasa a la sangre y llega a los riñones. Los riñones sí pueden filtrar esta forma de bilirrubina — por eso la orina de Sofía es marrón oscuro, como té. Y como la bilis no llega al intestino, las heces no tienen color — salen blancas o de color arcilla.”

(Sofía has something different. In Sofía, the liver is processing the bilirubin — conjugating the bilirubin, in medical terms — but that processed bile cannot exit the liver into the intestine. The bile ducts — the tubes that normally carry bile from the liver to the intestine — are closed. The bile gets trapped in the liver. When processed bile cannot exit through the ducts, it exits another way: it passes into the blood and reaches the kidneys. The kidneys can filter this form of bilirubin — which is why Sofía’s urine is dark brown, like tea. And because bile does not reach the intestine, the stools have no color — they come out white or clay-colored.)

Claudia glanced at the paper bag she had brought containing Sofía’s last diaper. “Las heces así llevan tres semanas,” she said quietly. “Yo no sabía que eso era importante.” (The stools have been like that for three weeks. I did not know that was important.)

“Ahora lo sabe. Y eso — las heces sin color y la orina oscura — son exactamente los síntomas que nos dicen que lo que tiene Sofía no es la ictericia normal de los recién nacidos. Es una atresia biliar — el proceso en el que los conductos biliares de fuera del hígado se cerraron después del nacimiento de Sofía por una inflamación que destruyó esos conductos. Sin la cirugía, la bilis sigue atrapaándose en el hígado, las células del hígado se siguen dañando, y el hígado hace cicatriz — cirrosis biliar. Sin tratar, los niños con atresia biliar desarrollan falla hepática en los primeros dos años de vida.”

(Now you know. And that — colorless stools and dark urine — are exactly the symptoms that tell us what Sofía has is not normal newborn jaundice. It is biliary atresia — the process in which the bile ducts outside the liver closed after Sofía’s birth due to an inflammation that destroyed those ducts. Without surgery, bile keeps getting trapped in the liver, the liver cells keep getting damaged, and the liver makes scar tissue — biliary cirrhosis. Untreated, children with biliary atresia develop liver failure in the first two years of life.)

Claudia had gone pale. “¿En los primeros dos años?” (In the first two years?)

“Sí. Y Sofía tiene ahora seis semanas. Por eso la cirugía es urgente — y por eso quiero explicarle la parte de la cirugía que tiene que ver con el tiempo.”

(Yes. And Sofía is now six weeks old. That is why the surgery is urgent — and that is why I want to explain to you the part of the surgery that has to do with timing.)

“La cirugía — la operación de Kasai — conecta el intestino delgado directamente a la puerta del hígado donde estaban los conductos biliares, para que la bilis pueda salir del hígado directamente al intestino sin necesitar los conductos que se cerraron. No restaura los conductos — los evita. Y la operación funciona mejor cuando los conductos biliares dentro del hígado — los conductos más pequeños, los que viven dentro del tejido del hígado mismo — todavía están intactos. Esos conductos interiores son los que permiten que la bilis salga una vez que la cirugía abre la vía exterior.”

(The surgery — the Kasai operation — connects the small intestine directly to the gateway of the liver where the bile ducts used to be, so that bile can exit the liver directly into the intestine without needing the closed ducts. It does not restore the ducts — it bypasses them. And the operation works best when the bile ducts inside the liver — the smaller ducts that live inside the liver tissue itself — are still intact. Those interior ducts are what allow bile to flow out once the surgery opens the exterior pathway.)

“¿Y si esos conductos de adentro también se cierran?” Claudia asked. (And if those interior ducts also close?)

“Esa es exactamente la pregunta. El mismo proceso inflamatorio que cerró los conductos externos sigue activo adentro del hígado. Mientras más tiempo pasa, más conductos internos se pierden. Los datos de miles de operaciones de Kasai en todo el mundo muestran lo mismo: si la operación se hace antes de los dos meses de edad — antes de los sesenta días — más del sesenta por ciento de los bebés logran un drenaje biliar adecuado y pueden evitar un trasplante de hígado por años, a veces para siempre. Si se hace entre los dos y los tres meses, el éxito baja al treinta a cuarenta por ciento. Después de los tres meses, menos del veinte al veinticinco por ciento. Después de los cuatro meses, la mayoría de los centros ya no hacen la operación porque los conductos interiores están demasiado destruidos para que funcione.”

(That is exactly the question. The same inflammatory process that closed the external ducts is still active inside the liver. The more time passes, the more internal ducts are lost. Data from thousands of Kasai operations worldwide show the same thing: if the operation is done before two months of age — before sixty days — more than sixty percent of babies achieve adequate bile drainage and can avoid a liver transplant for years, sometimes forever. If done between two and three months, success falls to thirty to forty percent. After three months, less than twenty to twenty-five percent. After four months, most centers no longer perform the operation because the interior ducts are too destroyed for it to work.)

Claudia sat with this. “Sofía tiene seis semanas.” (Sofía is six weeks old.)

“Sofía tiene cuarenta y dos días. La operación está programada para los día cuarenta y seis. Estamos en la ventana mejor para la cirugía — pero es una ventana, y cada semana que espera la ventana se estrecha. Lo que usted ve — Sofía comiendo bien, mirándola — es real. Sofía está compensando ahora. El daño dentro del hígado precede en meses a los síntomas que usted podría percibir. Para cuando Sofía parezca enferma desde afuera, los conductos interiores estarían demasiado destruidos para la operación.”

(Sofía is forty-two days old. The operation is scheduled for day forty-six. We are in the best window for the surgery — but it is a window, and every week we wait the window narrows. What you see — Sofía eating well, looking at you — is real. Sofía is compensating right now. The damage inside the liver precedes by months the symptoms you would be able to perceive. By the time Sofía seems sick from the outside, the interior ducts would be too destroyed for the operation.)

Claudia looked down at Sofía, who was asleep in her car seat with the characteristic amber-yellow tinge to her skin. “El color de la orina y las heces de Sofía me dicen que su hígado no puede drenar la bilis — no que tiene demasiada bilis por los glóbulos rojos. Son dos cosas distintas. Y la cirugía tiene que pasar esta semana porque cada semana que esperamos, el hígado de Sofía pierde más conductos por dentro que la operación necesita para funcionar.”

(The color of Sofía’s urine and stools tells me that her liver cannot drain the bile — not that she has too much bile from red blood cells. They are two different things. And the surgery has to happen this week because every week we wait, Sofía’s liver loses more interior ducts that the operation needs to work.)

“Exactamente,” Gabriela said. “Usted acaba de resumir exactamente lo que el equipo quiere que entienda antes de la cirugía. ¿Tiene preguntas sobre cómo va a ser el día de la operación?”

(Exactly. You just summarized exactly what the team wants you to understand before the surgery. Do you have questions about what the day of the operation will be like?)

They spent the next twenty minutes discussing the surgery itself — what Claudia would see when she arrived, how long the operation would take, what “success” meant after the Kasai (yellow color improving over weeks, stool color normalizing, bilirubin trend downward), and what the path would be if bile drainage was inadequate (liver transplant evaluation, which would begin at three months post-Kasai if bilirubin did not trend to near-normal). Claudia left with the consent forms signed and a clearer understanding of why the surgery that had seemed so urgent for a baby who appeared well was, in fact, the only window remaining.


Scenario 2: Carmen Delgado-Estrada — 12 years old, San Antonio, Texas

Carmen Delgado-Estrada had been brought to the pediatric liver disease clinic after her pediatrician found abnormal liver tests during a routine annual physical — an incidental finding that had led, over six weeks of escalating workup, to a liver biopsy and a diagnosis of autoimmune hepatitis type 1. Her ALT was 312 U/L and her AST 198 U/L. Her antinuclear antibody titer was 1:320 and her anti-smooth muscle antibody titer was 1:160. Her IgG was 2,840 mg/dL. The biopsy showed interface hepatitis with plasma cell infiltration and grade 2 portal fibrosis — a histological picture entirely consistent with autoimmune hepatitis and incompatible with viral hepatitis, medication-induced hepatitis, or fatty liver disease. Hepatitis A, B, and C serologies were all negative. She had no prior medications, no herbal supplements, and no family history of liver disease or autoimmune disorders.

The pediatric hepatologist had prescribed prednisone 60 mg daily for four weeks with a gradual taper and azathioprine 50 mg daily for long-term maintenance. The plan was to repeat liver enzymes every two weeks during the prednisone taper, and every three months thereafter. If aminotransferases normalized and IgG normalized, prednisone would be tapered to the lowest effective dose. Azathioprine was expected to be continued indefinitely.

Rosa Estrada-Morales, a school bus driver, had come to the appointment with Carmen and with two printed pages she had found on a health website about “hepatitis.” The pages were about hepatitis B and C. She had highlighted the transmission routes and the long-term complication risks.

“Tengo algunas preguntas,” she said to pediatric liver disease clinic nurse Elena Herrera-Santos. “El doctor dijo que Carmen tiene hepatitis autoinmune. Yo busqué hepatitis y lo que encontré es que la hepatitis viene de un virus. La hepatitis B se pega por sangre y por relaciones sexuales. La hepatitis C también por sangre. Carmen tiene doce años, no usa drogas, nunca le han puesto una transfusión. El análisis salió negativo para hepatitis B y C. Entonces ¿de dónde sacó Carmen una hepatitis?”

(I have some questions. The doctor said Carmen has autoimmune hepatitis. I searched for hepatitis and what I found is that hepatitis comes from a virus. Hepatitis B is transmitted through blood and sexual contact. Hepatitis C also through blood. Carmen is twelve years old, she does not use drugs, she has never had a transfusion. The test came back negative for hepatitis B and C. So where did Carmen get hepatitis from?)

Elena recognized immediately the linguistic trap that was generating Rosa’s confusion: the word “hepatitis” carrying the full viral hepatitis model, applied to a diagnosis that shared the name but shared nothing else with it.

“La pregunta de usted es exactamente la correcta, y viene de un problema con la palabra ‘hepatitis’ — una palabra que en la vida cotidiana casi siempre significa infecção viral, pero en medicina significa algo más amplio,” she said. “Quiero explicarle eso primero, porque si no entendemos de dónde viene la enfermedad de Carmen, nada más de lo que yo le explique va a tener sentido.”

(Your question is exactly the right one, and it comes from a problem with the word ‘hepatitis’ — a word that in everyday life almost always means viral infection, but in medicine means something broader. I want to explain that to you first, because if we do not understand where Carmen’s illness comes from, nothing else I explain will make sense.)

“Adelante,” Rosa said, setting down the printed pages. (Go ahead.)

“La palabra hepatitis viene del griego: ‘hepa’ significa hígado, e ‘itis’ significa inflamación. Hepatitis significa inflamación del hígado — eso es todo. La hepatitis A, B y C son infecciones virales que causan esa inflamación, y son las que usted buscó. Pero hay otras causas de inflamación del hígado que no son infecciosas. La hepatitis autoinmune de Carmen no es una infecção. Ningún virus la causó. Carmen no la adquirió de ninguna persona, ninguna exposición, y ningún comportamiento. No se puede contagiar a nadie.”

(The word hepatitis comes from Greek: ‘hepa’ means liver, and ‘itis’ means inflammation. Hepatitis means liver inflammation — that is all. Hepatitis A, B and C are viral infections that cause that inflammation, and those are the ones you looked up. But there are other causes of liver inflammation that are not infectious. Carmen’s autoimmune hepatitis is not an infection. No virus caused it. Carmen did not acquire it from any person, any exposure, or any behavior. It cannot be transmitted to anyone.)

Rosa put down her highlighted pages. “¿Entonces qué lo causó?” (So what caused it?)

“Lo que causó la hepatitis de Carmen es el propio sistema inmune de Carmen — el sistema de defensa del cuerpo, el que normalmente combate los gérmenes. En condiciones normales, ese sistema tiene un mecanismo de tolerancia que le enseña a los glóbulos blancos a no atacar los tejidos del propio cuerpo. En Carmen, ese mecanismo falló específicamente en el hígado. Los glóbulos blancos de Carmen — células T, en términos técnicos — empezaron a reconocer las células del hígado de Carmen como si fueran tejido extranjero y a atacarlas. El resultado es la misma inflamación que produciría una infección viral — células del hígado dañadas, enzimas hepáticas elevadas en la sangre — pero la causa es completamente diferente.”

(What caused Carmen’s hepatitis is Carmen’s own immune system — the body’s defense system, the one that normally fights germs. Under normal conditions, that system has a tolerance mechanism that teaches white blood cells not to attack the body’s own tissues. In Carmen, that mechanism failed specifically in the liver. Carmen’s white blood cells — T-cells, in technical terms — began recognizing Carmen’s liver cells as if they were foreign tissue and attacking them. The result is the same inflammation that a viral infection would produce — damaged liver cells, elevated liver enzymes in the blood — but the cause is completely different.)

Rosa was looking at the printed pages with a different expression now — like she was revising the model she had brought in. “¿Eso tiene que ver con los análisis que salieron positivos? El ANA y el anticuerpo contra el músculo?” (Does that have to do with the tests that came back positive? The ANA and the smooth muscle antibody?)

“Exactamente. El ANA — el anticuerpo antinuclear — y el anticuerpo contra el músculo liso son los anticuerpos que el propio sistema inmune de Carmen produce contra su hígado. Son las firmas del ataque: el cuerpo de Carmen está generando anticuerpos contra partes específicas de las células del hígado — el núcleo de las células y el tejido muscular que rodea los conductos biliares. Esos anticuerpos están en la sangre de Carmen porque su sistema inmune los está produciendo ahora mismo. Eso es lo que confirma el diagnóstico: no es un virus externo, es el sistema de defensa de Carmen confundido sobre a qué debe atacar.”

(Exactly. The ANA — antinuclear antibody — and the smooth muscle antibody are the antibodies that Carmen’s own immune system produces against her liver. They are the signatures of the attack: Carmen’s body is generating antibodies against specific parts of liver cells — the cell nucleus and the muscle tissue surrounding the bile ducts. Those antibodies are in Carmen’s blood because her immune system is producing them right now. That is what confirms the diagnosis: it is not an external virus, it is Carmen’s defense system confused about what it should attack.)

Rosa was quiet for a moment. “¿Por qué le pasó esto a Carmen? ¿Hice algo mal?” (Why did this happen to Carmen? Did I do something wrong?)

“No. La hepatitis autoinmune no es causada por ninguna acción de los padres ni de la niña. La causa exacta todavía no la entendemos completamente — hay una predisposición genética en algunas personas para que el mecanismo de tolerancia inmunológica falle en el hígado, probablemente desencadenado por alguna infección viral u otro estímulo ambiental que nadie pudo haber previsto ni evitado. No es culpa de nadie. Lo que sí sabemos es cómo tratarlo.”

(No. Autoimmune hepatitis is not caused by any action of the parents or the child. The exact cause we still do not fully understand — there is a genetic predisposition in some people for the immune tolerance mechanism to fail in the liver, probably triggered by some viral infection or other environmental stimulus that no one could have predicted or prevented. It is no one’s fault. What we do know is how to treat it.)

“¿Por qué el esteroide?” Rosa asked. (Why the steroid?)

“El esteroide — la prednisona — es un supresor inmune amplio. Reduce la actividad de todo el sistema inmune en las primeras semanas para detener el ataque agudo. Las enzimas del hígado de Carmen deben bajar significativamente en las primeras cuatro a seis semanas de prednisona. Después de eso, bajamos la dosis de prednisona gradualmente porque los esteroides a largo plazo tienen efectos secundarios que queremos minimizar — aumento de peso, aumento de azúcar en sangre, efectos sobre el crecimiento. El azatioprina — el otro medicamento — es más específico: inhibe la reproducción de los glóbulos blancos que están atacando el hígado, y mantiene la remisión a largo plazo con menos efectos secundarios que el esteroide solo.”

(The steroid — prednisone — is a broad immune suppressant. It reduces the activity of the entire immune system in the first weeks to stop the acute attack. Carmen’s liver enzymes should fall significantly in the first four to six weeks of prednisone. After that, we gradually lower the prednisone dose because long-term steroids have side effects we want to minimize — weight gain, elevated blood sugar, effects on growth. Azathioprine — the other medication — is more specific: it inhibits the reproduction of the white blood cells that are attacking the liver, and it maintains remission long-term with fewer side effects than steroids alone.)

“¿Cuánto tiempo tiene que tomar el azatioprina?” (How long does she have to take the azathioprine?)

“La mayoría de los pacientes con hepatitis autoinmune necesitan el azatioprina por muchos años, a menudo de por vida o casi. Los estudios muestran que cuando se suspenden los medicamentos después de que las enzimas se normalizan, la hepatitis regresa en el sesenta a ochenta por ciento de los pacientes en los primeros tres años. La biopsia de Carmen ya muestra fibrosis grado 2 — el tejido de cicatriz que se forma cuando la inflamación lleva meses. La meta del tratamiento es que esa cicatriz no avance más. La biopsia de seguimiento a los años de tratamiento nos dirá si lo logramos.”

(Most patients with autoimmune hepatitis need azathioprine for many years, often for life or nearly so. Studies show that when medications are stopped after enzymes normalize, the hepatitis returns in sixty to eighty percent of patients within the first three years. Carmen’s biopsy already shows grade 2 fibrosis — the scar tissue that forms when inflammation has been ongoing for months. The treatment goal is for that scar to not advance further. The follow-up biopsy after years of treatment will tell us if we achieved that.)

Rosa looked at the printed pages she had brought and folded them in half. “La hepatitis de Carmen no es una infección — nadie se la pegó y ella no se la puede pegar a nadie. Su sistema inmune está atacando su propio hígado por error, como si fuera tejido extraño. El esteroide para ese ataque y el azatioprina evita que los glóbulos blancos que atacan se reproduzcan. Sin los medicamentos, el ataque continúa y el hígado hace más cicatriz.”

(Carmen’s hepatitis is not an infection — no one gave it to her and she cannot give it to anyone. Her immune system is attacking her own liver by mistake, as if it were foreign tissue. The steroid stops that attack and azathioprine prevents the attacking white blood cells from reproducing. Without the medications, the attack continues and the liver makes more scar tissue.)

“Eso es exactamente lo que necesitaba entender,” Elena confirmed. “¿Quiere que expliquemos esto mismo a las personas de la familia que tienen preguntas?”

(That is exactly what you needed to understand. Would you like us to explain this same thing to the family members who have questions?)

Rosa nodded. They arranged for a family call the following week with Elena as the interpreter of the diagnosis, and Carmen left with her prescriptions and a printed summary of her diagnosis in Spanish that used the phrase “inflamación autoinmune del hígado” rather than “hepatitis” anywhere in the first paragraph, specifically because of this conversation.


Scenario 3: Diego Martínez-Reyes — 14 years old, Dallas, Texas

Diego Martínez-Reyes had been referred to the pediatric liver disease clinic from his primary care pediatrician after the annual metabolic syndrome monitoring panel showed an ALT of 78 U/L, an AST of 52 U/L, fasting triglycerides of 168 mg/dL, HDL cholesterol of 32 mg/dL, and a fasting glucose of 108 mg/dL. His BMI was 34 and his waist circumference was at the ninety-eighth percentile for his age. A liver ultrasound performed by the pediatrician had shown “diffusely increased echogenicity consistent with grade 2 hepatic steatosis with vascular blurring.” The clinic had added a fibroscan, which measured liver stiffness at 7.2 kPa — above the pediatric normal range of less than 5.5 kPa, in the borderline-to-mild fibrosis range by METAVIR criteria. Hepatitis B and C serologies were negative. ANA, ceruloplasmin, alpha-1-antitrypsin level, and TSH were all normal. There were no medications, no herbal supplements, and no alcohol use — Diego’s parents confirmed he did not drink.

Armando Martínez-Torres, Diego’s father and a long-haul truck driver, had arrived at the appointment with a specific concern. He had looked up “hígado graso” and the first results he had found were about alcoholic liver disease — “hígado graso alcóholico” — and steatohepatitis in heavy drinkers. He had also found a Spanish-language video about “cómo el alcohol destruye el hígado” that showed ultrasound images identical to what the pediatrician had described for Diego. He was not angry. He was confused and, underneath the confusion, there was something that felt to him like an implied accusation that he was reading into the diagnosis.

“Quiero entender algo antes de empezar,” he said to pediatric liver disease clinic nurse Ana Villanueva-Cruz. “El ultrasonido dice que Diego tiene grasa en el hígado. Todo lo que encontré sobre el hígado graso habla de personas que toman mucho alcohol. Diego no toma. Yo sé que no toma. Su madre sabe que no toma. ¿Cómo tiene un hígado graso un niño que no toma?”

(I want to understand something before we start. The ultrasound says Diego has fat in his liver. Everything I found about fatty liver talks about people who drink a lot of alcohol. Diego does not drink. I know he does not drink. His mother knows he does not drink. How does a boy who does not drink have fatty liver disease?)

Ana had encountered this conversation many times with parents of adolescents with MASLD. The “hígado graso” search result problem was well known in the clinic — it was why the educational materials had been updated the previous year to lead with the two-mechanism explanation.

“Tiene razón al preguntar eso, y tiene razón en que Diego no bebe — eso es consistente con todo lo que vemos en el historial,” she said. “La confusión viene de que hay dos causas distintas del hígado graso, y cuando uno busca en internet normalmente encuentra la que está asociada con el alcohol primero. Quiero explicarle las dos, porque la de Diego no tiene nada que ver con el alcohol.”

(You are right to ask that, and you are right that Diego does not drink — that is consistent with everything we see in the history. The confusion comes from the fact that there are two distinct causes of fatty liver, and when you search the internet you usually find the one associated with alcohol first. I want to explain both to you, because Diego’s has nothing to do with alcohol.)

Armando leaned forward. “Adelante.” (Go ahead.)

“La primera causa es el alcohol. El alcohol se convierte en una sustancia tóxica en el hígado que daña las células y al mismo tiempo hace que el hígado produzca y acumule grasa. Sin alcohol, ese proceso no ocurre. Esa es la causa que usted encontró. La segunda causa es la resistencia a la insulina — que ocurre sin ningún alcohol. La resistencia a la insulina es cuando las células del cuerpo — incluyendo las del hígado — no responden bien a la insulina que produce el páncreas. La insulina es la señal que le dice al hígado cuándo parar de convertir azúcar en grasa. Con resistencia a la insulina, el hígado no recibe bien esa señal de “para.” Sigue convirtiendo los carbohidratos de la comida — el pan, el arroz, el azúcar, los refrescos — en grása, más de lo que puede exportar. Esa grasa se acumula en las células del hígado. Y eso es lo que el ultrasonido ve.”

(The first cause is alcohol. Alcohol is converted into a toxic substance in the liver that damages cells and at the same time causes the liver to produce and accumulate fat. Without alcohol, that process does not occur. That is the cause you found. The second cause is insulin resistance — which occurs without any alcohol. Insulin resistance is when the body’s cells — including liver cells — do not respond well to the insulin produced by the pancreas. Insulin is the signal that tells the liver when to stop converting sugar into fat. With insulin resistance, the liver does not receive that ‘stop’ signal well. It keeps converting carbohydrates from food — bread, rice, sugar, sodas — into fat, more than it can export. That fat accumulates in liver cells. And that is what the ultrasound sees.)

Armando absorbed this. “¿De dónde viene la resistencia a la insulina de Diego?” (Where does Diego’s insulin resistance come from?)

“La resistencia a la insulina en Diego viene del exceso de grasa visceral — la grasa que se acumula alrededor de los órganos del abdomen. Esa grasa no es solo almacenamiento — produce sustancias inflamatorias que circulan en la sangre y llegan al hígado e interfieren con la señal de la insulina. Cuanta más grasa visceral, más resistencia a la insulina, y más grasa acumula el hígado. El análisis que hicimos también mostró que Diego tiene los triglicéridos altos y el HDL bajo — esos son los otros marcadores del síndrome metabólico, que es el nombre para el conjunto de cambios que el exceso de grasa visceral produce en el metabolismo. El hígado graso de Diego es parte del síndrome metabólico — no del alcohol.”

(The insulin resistance in Diego comes from excess visceral fat — the fat that accumulates around the abdominal organs. That fat is not just storage — it produces inflammatory substances that circulate in the blood, reach the liver, and interfere with the insulin signal. The more visceral fat, the more insulin resistance, and the more fat the liver accumulates. The test we did also showed that Diego has elevated triglycerides and low HDL — those are the other markers of metabolic syndrome, which is the name for the cluster of metabolic changes that excess visceral fat produces. Diego’s fatty liver is part of metabolic syndrome — not of alcohol.)

Armando looked at Diego, who was sitting quietly across the room looking at his phone. “¿Y por qué tiene que vigilarse?” (And why does it need to be monitored?)

“Porque el hígado graso que viene del síndrome metabólico puede progresar con el tiempo. La mayoría de las personas tienen solo la grasa — lo que llamamos esteatosis simple — y están estables por muchos años. Pero en aproximadamente el veinte a treinta por ciento de las personas con hígado graso metabólico, la grasa produce inflamación activa en las células del hígado, y esa inflamación genera tejido de cicatriz — fibrosis. La fibrosis puede progresar a cirrosis. La medida del fib róscan que hicimos hoy — el 7.2 kPa — está por encima del rango normal, lo que nos dice que Diego ya tiene algo de cicatriz. No es cirrosis — está lejos de cirrosis. Pero nos dice que el proceso ya no es solo grasa simple.”

(Because fatty liver from metabolic syndrome can progress over time. Most people only have the fat — what we call simple steatosis — and are stable for many years. But in approximately twenty to thirty percent of people with metabolic fatty liver, the fat produces active inflammation in liver cells, and that inflammation generates scar tissue — fibrosis. Fibrosis can progress to cirrhosis. The fibroscan measurement we did today — 7.2 kPa — is above the normal range, which tells us Diego already has some scar tissue. It is not cirrhosis — it is far from cirrhosis. But it tells us the process is no longer just simple fat.)

Armando’s expression had shifted from defensive to concerned. “¿Se puede curar?” (Can it be cured?)

“Se puede mejorar significativamente — y en Diego, que tiene catorce años, el tratamiento más importante es el que más cambia el rumbo a largo plazo. Una baja de peso del cinco al diez por ciento — que para Diego sería entre cinco y ocho kilogramos — reduce la grasa en el hígado de manera significativa, baja las enzimas del hígado, y reduce la rigidez que mide el fibróscan. Eso pasa porque al bajar la grasa visceral, el hígado recupera la sensibilidad a la insulina y para de producir tanta grasa. El ejercicio aeróbico regular — caminar, nadar, andar en bicicleta, cuarenta y cinco minutos tres o cuatro veces por semana — también mejora la sensibilidad a la insulina independientemente del peso. Y reducir el azúcar y los carbohidratos refinados — especialmente los refrescos y jugos — quita el principal material que el hígado convierte en grasa.”

(It can improve significantly — and in Diego, who is fourteen years old, the most important treatment is the one that most changes the long-term trajectory. A weight loss of five to ten percent — which for Diego would be between five and eight kilograms — reduces liver fat significantly, lowers liver enzymes, and reduces the stiffness the fibroscan measures. That happens because when visceral fat decreases, the liver recovers insulin sensitivity and stops producing so much fat. Regular aerobic exercise — walking, swimming, cycling, forty-five minutes three or four times per week — also improves insulin sensitivity independent of weight. And reducing sugar and refined carbohydrates — especially sodas and juices — removes the main material the liver converts into fat.)

Diego had put down his phone and was listening. “¿Los refrescos?” (Sodas?)

“El azúcar de los refrescos y los jugos — especialmente la fructosa del jarabe de maíz alto en fructosa — es el carbohidrato más lipogénico que existe: el hígado lo convierte en grasa de manera muy eficiente. Un estudio mostró que reemplazar las bebidas azucaradas con agua en adolescentes con hígado graso redujo la esteatosis hepática significativamente en solo ocho semanas, sin ningún otro cambio.”

(The sugar in sodas and juices — especially the fructose from high-fructose corn syrup — is the most lipogenic carbohydrate that exists: the liver converts it into fat very efficiently. One study showed that replacing sugary beverages with water in adolescents with fatty liver significantly reduced hepatic steatosis in just eight weeks, with no other change.)

Armando looked at his son. Diego was looking at the floor. “¿Cuántos refrescos tomas al día?” (How many sodas do you drink a day?)

Diego shrugged. “Tres, tal vez cuatro.” (Three, maybe four.)

A silence. Then Armando looked at Ana. “El hígado graso de Diego no tiene nada que ver con el alcohol. Viene de que las células del hígado producen demasiada grasa de los carbohidratos — porque el exceso de grasa en el abdomen le quitó al hígado la señal de parar. La grasa en el hígado puede hacer cicatriz con el tiempo. Por eso necesitamos vigilarlo — y por eso los refrescos tienen que parar.”

(Diego’s fatty liver has nothing to do with alcohol. It comes from the liver cells producing too much fat from carbohydrates — because excess fat in the abdomen took away the liver’s signal to stop. The fat in the liver can make scar tissue over time. That is why we need to monitor it — and that is why the sodas have to stop.)

“Eso es todo,” Ana said. “Usted resume perfectamente lo que Diego necesita entender para tomar eso en serio.” (That is everything. You summarize perfectly what Diego needs to understand to take this seriously.)

They discussed the follow-up plan: ALT and fasting lipid panel in six weeks to assess dietary response, a repeat fibroscan in one year to assess fibrosis trajectory, and a referral to the pediatric dietitian for a structured eating plan focused on sugar and refined carbohydrate reduction. Diego left the clinic with a handout titled “El hígado graso de Diego no viene del alcohol” — written specifically for this conversation — and with his phone open to a calculator showing what five percent of his body weight looked like in kilograms.


FAQ: Spanish for pediatric liver disease clinic nurses

How do pediatric liver disease nurses explain biliary atresia and the urgency of Kasai portoenterostomy to Spanish-speaking parents who believe their jaundiced baby is otherwise well?

The biliary atresia conversation requires establishing the distinction between physiological unconjugated jaundice (normal in newborns, stool yellow, urine pale) and pathological conjugated hyperbilirubinemia (always abnormal, clay-colored stools, dark amber urine). Biliary atresia destroys the extrahepatic bile ducts; bile accumulates in the liver and causes progressive biliary cirrhosis. The Kasai portoenterostomy success rate exceeds sixty percent before sixty days of age and falls below twenty percent after ninety days. The key phrase: “La orina oscura y las heces de arcilla me dicen que la bilis no sale del hígado al intestino — eso no es la ictericia normal. La cirugía tiene que pasar esta semana porque cada semana que esperamos, el hígado pierde más conductos por dentro que la operación necesita para funcionar.”

How do pediatric liver disease nurses explain autoimmune hepatitis immunosuppression to Spanish-speaking parents who confuse it with viral hepatitis?

The nurse must first decouple the word “hepatitis” from the viral model: hepatitis means liver inflammation, not liver infection. Autoimmune hepatitis is a T-cell immune attack on hepatocyte antigens (ANA, anti-smooth muscle antibody) — not infectious, not contagious, not caused by behavior. Immunosuppression (prednisone + azathioprine) halts the immune attack and prevents fibrosis progression. Most patients require azathioprine indefinitely. The key phrase: “La hepatitis autoinmune de Carmen no es una infección — nadie se la pegó y no se puede pegar. Su sistema inmune ataca su propio hígado por error. El esteroide para ese ataque; el azatioprina evita que los glóbulos blancos que atacan se reproduzcan.”

How do pediatric liver disease nurses explain MASLD to Spanish-speaking parents who believe fatty liver only affects people who drink alcohol?

The nurse must establish the two-mechanism model: alcoholic liver disease (ethanol → acetaldehyde toxicity + lipogenesis) versus MASLD (insulin resistance from visceral adiposity → unregulated hepatic de novo lipogenesis from dietary carbohydrates). MASLD is the most common pediatric liver disease in the US. The fibroscan finding indicates early fibrosis already present. The key phrase: “El hígado graso de Diego no viene del alcohol. Viene de que la grasa del abdomen le quitó al hígado la señal de parar de convertir carbohidratos en grasa. La vigilancia es porque esa grasa puede hacer cicatriz — y queremos cambiar el rumbo ahora, a los catorce, no esperar a que sea un problema más grande.”

What are the clinical Spanish phrases pediatric liver disease nurses use most often?

For biliary atresia: “Las heces de arcilla y la orina marrón oscuro son señales de que la bilis no llega al intestino. En la ictericia normal del recién nacido, las heces son amarillas y la orina es pálida. La diferencia entre esas dos cosas es la diferencia entre una situación que espera sola y una que necesita cirugía urgente.” For autoimmune hepatitis: “Los análisis positivos — el ANA y el anticuerpo de músculo liso — son anticuerpos que el propio cuerpo de Carmen produce contra su hígado. Son la firma del ataque inmunológico. No son una infección.” For MASLD: “La resistencia a la insulina que viene del sobrepeso en el abdomen hace que el hígado convierta los carbohidratos — especialmente el azúcar y los refrescos — en grasa sin poder parar. Bajar de peso le devuelve al hígado la señal de para.”

Why is early diagnosis of pediatric liver disease critical, and how do nurses explain the long-term risks to Spanish-speaking families?

Biliary atresia is a surgical emergency with a closing treatment window: the Kasai portoenterostomy must be performed before sixty days of age to achieve sixty-plus percent success; delay beyond ninety days reduces success to under twenty percent. Autoimmune hepatitis produces progressive hepatic fibrosis that leads to cirrhosis if untreated; Carmen’s biopsy showing grade 2 fibrosis at age twelve documents months of ongoing immune injury before diagnosis. MASLD in adolescents with metabolic syndrome and early fibrosis (fibroscan 7.2 kPa at fourteen) has decades ahead for progression; the window for lifestyle intervention that reverses fibrosis is now, not after cirrhosis develops. The nurse’s communication task in each case is to translate invisible biochemical processes into the language of urgency — the jaundice that looks benign, the liver tests with no symptoms, the ultrasound finding in an otherwise active teenager — and to explain why the clinical team’s sense of urgency is grounded in the biology of time-sensitive disease, not overcaution.


Practice these conversations with ClinicaLingo

Clinical-Spanish fluency in pediatric liver disease conversations requires practicing the explanations, not just memorizing the vocabulary. ClinicaLingo offers AI-voiced roleplay scenarios where you practice explaining biliary atresia urgency, autoimmune hepatitis immunosuppression, and pediatric MASLD to Spanish-speaking parents — with tap-to-translate transcripts and spaced-repetition recall to build the phrases you need before the clinical encounter.

Practice pediatric liver disease conversations →

For the foundational clinical Spanish that every nurse needs regardless of specialty, download our free 50 Spanish ED phrases PDF — useful on any shift, no login required.


Related posts: Spanish for hepatology clinic nurses · Spanish for pediatric gastroenterology clinic nurses · Spanish for pediatric infectious disease clinic nurses · Spanish for pediatric nurses · Spanish for pediatric surgery nurses · Spanish for autoimmune hepatitis clinic nurses · All posts